IGF-1 LR3

IGF-1 LR3 stands for Long Arg3 IGF-1. IGF-1 is a natural growth signal your body makes. It is one of the main ways growth hormone builds muscle.

Normally your body clears IGF-1 fast, in about 10 minutes. Special carrier proteins grab it and switch it off. LR3 is changed in two spots so those carriers cannot grab it. So it stays active far longer, about 20 to 30 times longer than the natural kind.

That long, free-floating growth signal is exactly what bodybuilders are buying. It is also exactly what makes it risky.

Note: native IGF-1 (the drug Increlex, also called mecasermin) is FDA-approved, but that is a different molecule for sick kids. LR3 is the off-label, non-approved version.

Almost everyone using IGF-1 LR3 is a bodybuilder.

They use it to build muscle, recover faster, and push past what training alone gives. People who "graduate" from a milder compound called MK-677 often move to it for a more direct effect.

It is not used for any medical condition. The FDA-approved cousin (Increlex) is for a rare childhood deficiency, which is a completely different situation.

For building muscle in healthy adults, there is no real proof. There are zero randomized human trials for performance.

What exists is animal data (it builds protein in rats) and bodybuilder reports of better recovery and some size gain over a few weeks. That is not the same as proven.

So you are taking on a serious cancer worry and a real low-blood-sugar risk in exchange for an effect that was never properly tested in people.

People take it as a small shot under the skin, daily.

The off-label range bodybuilders use is around 50–100 mcg a day. Effects on body shape are reported at 2 to 4 weeks. There is no official dosing, because it was never approved.

A real danger here is timing and blood sugar (more on that below). Because it acts a little like insulin, the dose and what you eat around it matter a lot.

The serious stuff

• The cancer worry is the headline. IGF-1 is a growth signal, and LR3 keeps that signal switched on for a long time. A big review (Renehan, Lancet 2004) linked higher IGF-1 to more breast, prostate, and colon cancer. Whether injecting LR3 raises your risk is unknown, and nobody is running that trial. If you have a personal or family history of those cancers, this is the wrong molecule, full stop.
• Low blood sugar. LR3 can drop your blood sugar suddenly. That can be dangerous. Sellers rarely warn about it.
• It is banned by WADA. Tested athletes will fail.

This is the molecule we most strongly warn against. We are not your doctor, but if you read one of these pages twice, make it this one.

Here are the lanes.

• Brand: none for LR3. (The approved drug Increlex is a different molecule for kids and costs a fortune.)
• Compounded: not available. There is no legal compounding path for LR3.
• Research-only (RUO): the whole off-label channel. About $80–$180 a month. Purity and identity are unverified.
• Gray-market overseas raw: $30–$70 a month, illegal to import for use.

Big red flag: vials labeled "IGF-1 LR3" very often ship as plain native IGF-1, which is the cheaper kind. Native IGF-1 lasts a fraction as long. So you carry the same low-blood-sugar risk but lose the LR3 effect you paid for. A mass-spec weight check (about 9.1 kDa for LR3 vs 7.6 kDa for native) is the only honest way to tell them apart.